In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.

Input: Consider Input: Verifying Authority and Legality In Drug Compounding Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) with respect to the regulation of compounding drugs.

Eliminates authority for compounding pharmacies to: (1) compound drugs before the receipt of a valid prescription order, or (2) compound any drug product that is a copy of a commercially available drug.

Requires the Secretary of Health and Human Services (HHS) to develop, maintain and transmit to the appropriate state agencies a list of drug products that should not be compounded, including: (1) drug products whose compounding is reasonably likely to cause an adverse effect on their safety or effectiveness; and (2) drug products that have been withdrawn or removed from the market because they have been found to be unsafe or not effective.

Authorizes the Secretary to waive the requirement that a drug product must be compounded for an individually identified patient based on a valid prescription order or similar notation if compounding the drug product is necessary to address a drug shortage, or to protect public health or well-being. Prohibits the Secretary from authorizing a state to grant such waivers.

Authorizes the Secretary to waive the requirement that a drug product must be compounded for an individually identified patient based on a valid prescription order or similar notation if the pharmacy or pharmacist: (1) submits a satisfactory application to the Secretary; and (2) agrees to comply with any condition or limitation specified by the Secretary. Makes a pharmacy or pharmacist required to be registered under the FFDCA as a drug producer ineligible for a waiver. Permits the Secretary to authorize a state to grant such waivers applicable to compounded drug products sold or dispensed within the state pursuant to a memorandum of understanding between the Secretary and the state.

Authorizes the Secretary to waive the prohibition against compounding any drug product that is a copy of a commercially available drug if it is necessary to protect public health or well-being. Prohibits the Secretary from authorizing a state to waive such prohibition.

Subjects the facilities of any pharmacy receiving a waiver under this Act to inspection to determine compliance with this Act.

Requires the Secretary to publish notice at least 30 days before cancelling a waiver, unless it is necessary to prevent an adverse impact on public health or safety.

Sets forth a required label statement for any drug compounded pursuant to this Act.

 Requires a pharmacist or physician compounding a drug product to report any adverse event associated with the use of the product within a specified time frame.

Output: To amend the Federal Food, Drug, and Cosmetic Act to provide for the compounding of drug products.


Input: Consider Input: Federal Health Care Board Act of 2007 - Establishes the Federal Health Care Board as an independent agency in the executive branch.

Requires the Board to: (1) ensure that Americans have access to health insurance and are provided certain basic facts about health care services prior to receiving care; (2) ensure that providers are delivering safe, evidence-based, high quality care and are transparent about pricing through disclosure of actual costs; (3) demand transparency for disclosure of actual costs and pricing from providers and payers through an information clearinghouse; (4) establish a national standard for a basic health insurance plan (including a basic minimum policy and the regional cost for such policy), a national protocol and standard for secure, universal, and individual electronic medical records, a national standard for public health services (including safety net providers), loan forgiveness and scholarship programs for health care providers who serve in underserved areas, and model dispute resolution procedures for malpractice claims that states may adopt; and (5) monitor progress toward those objectives.

Directs the Board's Board of Governors to establish 12 regions of the United States. Establishes in each region a Regional Board, based in a major city, to provide the Board of Governors with considerations that are relevant to their region's population.

Output: A bill to provide for the establishment of the Federal Health Care Board.


Input: Consider Input: Equal Access to Congressional Research Service Reports Act of 2016 This bill directs the Government Publishing Office (GPO) to establish and maintain a public website containing Congressional Research Service (CRS) Reports, and an index, that are searchable, sortable, and downloadable (including in bulk), for which no fee may be charged. The CRS Reports on the website shall include CRS Authorization of Appropriations Products, Appropriations Products, and any other written CRS product containing CRS research or analysis available for general congressional access on the CRS Congressional Intranet. The website shall exclude any:  custom product or service prepared in direct response to a request for custom analysis or research and not available for general congressional access on the CRS Congressional Intranet; CRS Reports, Authorization of Appropriations Products, or Appropriations Products not so available; or written CRS products that CRS has made available on a public website (besides this website) maintained by the GPO or the Library of Congress.  The GPO shall ensure that the website is updated contemporaneously, automatically, and electronically to include each new or updated CRS Report. Before transmitting a CRS Report to the GPO for publication on the website, CRS may remove the name of, and any contact information for, any CRS employee. The Legislative Reorganization Act of 1946 is amended to require CRS to comply with this Act.


Output: Equal Access to Congressional Research Service Reports Act of 2016